/

Anagrelide

Overview

Anagrelide is a drug used for the treatment of essential thrombocytosis, or overproduction of blood platelets. It also has been used in the treatment of chronic myeloid leukemia. Anagrelide controlled release is in phase III clinical trials by Galena Biopharma for the treatment of essential thrombocytosis

Anant Labs manufacture and furnish high quality Anagrelide impurities for global markets. Our Anagrelide EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Active Pharmaceutical Ingredient

Chemical structure of Anagrelide

Anagrelide

Mol. Formula: C₁₀H₇Cl₂N₃O
Mol. Weight: 256.092

Impurities (4)

Chemical structure of Anagrelide Ethyl ester

Anagrelide Ethyl ester

Cat. No.: ANT-ANG-02
CAS: 70381-75-8
Mol. Formula: C₁₂H₁₄BrCl₂N₃O₂
Mol. Weight: 302.16

Chemical structure of Anagrelide Methyl ester

Anagrelide Methyl ester

Cat. No.: ANT-ANG-01
CAS: 752151-24-9
Mol. Formula: C₁₁H₁₁Cl₂N₃O₂
Mol. Weight: 288.13

Chemical structure of Anagrelide USP Related Compound A

Anagrelide USP Related Compound A

Cat. No.: ANT-ANG-003
CAS: 70406-92-7
Mol. Formula: C₁₁H₁₄Cl₂N₂O₂
Mol. Weight: 277.15

Chemical structure of Anagrelide USP Related Compound B (HBr salt)

Anagrelide USP Related Compound B (HBr salt)

Cat. No.: ANT-ANG-004
CAS: 1194434-39-3
Mol. Formula: C₁₀H₉Cl₂N₃O₂.HBr
Mol. Weight: 355.02